Researcher Samuel Cohen explains how Alzheimer’s differs from normal memory loss and how that may hold the key for future treatments.
More than 40 million people worldwide suffer from Alzheimer's disease, and that number is expected to increase drastically in the coming years. But no real progress has been made in the fight against the disease since its classification more than 100 years ago. Scientist Samuel Cohen shares a new breakthrough in Alzheimer's research from his lab as well as a message of hope. "Alzheimer's is a disease," Cohen says, "and we can cure it."
About the Author
Samuel Cohen
Samuel Cohen is a Research Fellow in Biophysical Chemistry at St. John's College and the Centre for Misfolding Diseases in the Department of Chemistry at the University of Cambridge, from where he holds PhD, MSci, MA and BA degrees.